Effect of naloxone on the neuropsychiatric symptoms of a woman with partial adrenal 21-hydroxylase deficiency.
A woman with a schizophreniform syndrome, drug-induced dyskinetic movements, and partial adrenocortical 21-hydroxylase deficiency was given short-term treatment with naloxone, which ameliorated the psychiatric symptoms and eliminated the dyskinetic movements.
D000312:Adrenal Hyperplasia, Congenital; D000328:Adult; D004409:Dyskinesia, Drug-Induced / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D013255:Steroid 21-Hydroxylase; D013250:Steroid Hydroxylases / Q000172:deficiency*
D009270:Naloxone; D013250:Steroid Hydroxylases; D013255:Steroid 21-Hydroxylase